{"id":6,"date":"2012-11-21T13:27:03","date_gmt":"2012-11-21T11:27:03","guid":{"rendered":"http:\/\/solvent-trap.iip.de\/?page_id=6"},"modified":"2021-07-19T10:01:34","modified_gmt":"2021-07-19T08:01:34","slug":"applications","status":"publish","type":"page","link":"https:\/\/analyte.de\/?page_id=6","title":{"rendered":"Anwendung"},"content":{"rendered":"

Applikation DK29<\/h2>\n

\"Appl-12-DK29\"<\/a><\/p>\n

Applikation DK02<\/h2>\n

\"app09-DK02\"<\/a><\/p>\n

Applikation DJ16<\/h2>\n

\"app08-DJ16\"<\/a><\/p>\n

Applikation LC001833<\/h2>\n

\"appl07-LC001833\"<\/a><\/h2>\n

Applikation LC001789<\/h2>\n

\"appl06-LC001789\"<\/a><\/p>\n

\u00a0Applikation LC000831<\/h2>\n

\"APP01-LC000831\"<\/a><\/p>\n

\u00a0 Applikation LC00826<\/h2>\n

\"APP03-LC000826\"<\/a><\/p>\n

Applikation LC000857<\/h2>\n

\"APP04-LC000857\"<\/a><\/p>\n

Applikation LC001776<\/h2>\n

\"APP05-LC001776\"<\/a><\/p>\n

Applikation LC002342 – UV 243 nm<\/h2>\n

\"APP10-LC002342-243\"<\/a><\/p>\n

Applikation LC002342 – UV 274 nm<\/h2>\n

\"APP11-LC002342-274\"<\/a><\/p>\n

Gradientenmethoden aus European Pharmacopoeia (Ph. Eur.) \/ Pharmeuropa Monographien bei denen die Ghost-Guard-LC eingesetzt werden kann<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Substance<\/th>\nMonograph<\/th>\nTest<\/th>\nDetection<\/th>\n<\/tr>\n
Aciclovir<\/td>\nPharmeuropa XXXX:0968<\/td>\nRelated substances<\/td>\nspectrophotometer at 254 nm<\/td>\n<\/tr>\n
Aprotinin concentrated solution<\/td>\nPharmeuropa XXXX:0579<\/td>\nRelated substances<\/td>\nspectrophotometer at 215 nm<\/td>\n<\/tr>\n
Aprotinin concentrated solution<\/td>\nPharmeuropa XXXX:0579<\/td>\nPyroglutamyl-aprotinin and related compounds<\/td>\nspectrophotometer at 210\u00a0nm<\/td>\n<\/tr>\n
Aripiprazole<\/td>\nPharmeuropa XXXX:2617<\/td>\nAssay<\/td>\nspectrophotometer at 330\u00a0nm<\/td>\n<\/tr>\n
Aripiprazole<\/td>\nPharmeuropa XXXX:2617<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 254 nm<\/td>\n<\/tr>\n
Baical skullcap root<\/td>\nPharmeuropa XXXX:2438<\/td>\nAssay<\/td>\nspectrophotometer at 280 nm<\/td>\n<\/tr>\n
Calcium pantothenate<\/td>\nPharmeuropa XXXX:0470<\/td>\nRelated substances<\/td>\nspectrophotometer at 200\u00a0nm<\/td>\n<\/tr>\n
Caspofungin acetate<\/td>\nPharmeuropa XXXX:3029<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 205 nm<\/td>\n<\/tr>\n
Codeine phosphate sesquihydrate<\/td>\nPharmeuropa XXXX:0075<\/td>\nRelated substances<\/td>\nspectrophotometer at 280 nm<\/td>\n<\/tr>\n
Cyproheptadine hydrochloride sesquihydrate<\/td>\nPharmeuropa XXXX:0817<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 230 nm<\/td>\n<\/tr>\n
Dapsone<\/td>\nPharmeuropa XXXX:0077<\/td>\nRelated substances<\/td>\nspectrophotometer at 254 nm<\/td>\n<\/tr>\n
Dexamethasone sodium phosphate<\/td>\nPharmeuropa XXXX:0549<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 254 nm<\/td>\n<\/tr>\n
Dexpanthenol<\/td>\nPharmeuropa XXXX:0761<\/td>\nRelated substances<\/td>\nspectrophotometer at 200\u00a0nm<\/td>\n<\/tr>\n
Dipotassium clorazepate monohydrate<\/td>\nPharmeuropa XXXX:0898<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 230 nm<\/td>\n<\/tr>\n
Erythromycin<\/td>\nPharmeuropa XXXX:0179<\/td>\nAssay<\/td>\nspectrophotometer at 210\u00a0nm<\/td>\n<\/tr>\n
Erythromycin<\/td>\nPharmeuropa XXXX:0179<\/td>\nRelated substances<\/td>\nspectrophotometer at 210\u00a0nm<\/td>\n<\/tr>\n
Erythropoietin concentrated solution<\/td>\nPharmeuropa XXXX:1316<\/td>\nPeptide mapping<\/td>\nspectrophotometer at 214 nm<\/td>\n<\/tr>\n
Etomidate<\/td>\nPharmeuropa XXXX:1514<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 235\u00a0nm<\/td>\n<\/tr>\n
Flubendazole<\/td>\nPharmeuropa XXXX:1721<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 250 nm<\/td>\n<\/tr>\n
Fluticasone propionate<\/td>\nPharmeuropa XXXX:1750<\/td>\nRelated substances<\/td>\nspectrophotometer at 239\u00a0nm<\/td>\n<\/tr>\n
Forsythia fruit<\/td>\nPharmeuropa XXXX:2720<\/td>\nAssay<\/td>\nspectrophotometer at 325 nm<\/td>\n<\/tr>\n
Gallium (68Ga) PSMA-11 injection<\/td>\nPharmeuropa XXXX:3044<\/td>\nRelated substances<\/td>\nspectrophotometer at 280\u00a0nm<\/td>\n<\/tr>\n
Gemcitabine hydrochloride<\/td>\nPharmeuropa XXXX:2306<\/td>\nRelated substances<\/td>\nspectrophotometer at 275 nm<\/td>\n<\/tr>\n
Glipizide<\/td>\nPharmeuropa XXXX:0906<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 225 nm<\/td>\n<\/tr>\n
Hawthorn leaf and flower<\/td>\nPharmeuropa XXXX:1432<\/td>\nAssay<\/td>\nspectrophotometer at 340 nm<\/td>\n<\/tr>\n
Hawthorn leaf and flower dry extract<\/td>\nPharmeuropa XXXX:1865<\/td>\nAssay<\/td>\nspectrophotometer at 340 nm<\/td>\n<\/tr>\n
Hawthorn leaf and flower liquid extract<\/td>\nPharmeuropa XXXX:1864<\/td>\nAssay<\/td>\nspectrophotometer at 340 nm<\/td>\n<\/tr>\n
Levomepromazine maleate<\/td>\nPharmeuropa XXXX:0925<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 253 nm<\/td>\n<\/tr>\n
Lovastatin<\/td>\nPharmeuropa XXXX:1538<\/td>\nAssay<\/td>\nspectrophotometer at 238 nm<\/td>\n<\/tr>\n
Lovastatin<\/td>\nPharmeuropa XXXX:1538<\/td>\nRelated substances<\/td>\nspectrophotometer at 238 nm<\/td>\n<\/tr>\n
Macrogol poly(vinyl alcohol) grafted copolymer<\/td>\nPh. Eur. 01\/2013:2523<\/td>\nImpurity\u00a0A<\/td>\nspectrophotometer at 205\u00a0nm<\/td>\n<\/tr>\n
Mebendazole<\/td>\nPh. Eur. 04\/2013:0845<\/td>\nRelated substances<\/td>\nspectrophotometer at 250\u00a0nm<\/td>\n<\/tr>\n
Meclozine dihydrochloride<\/td>\nPh. Eur. 01\/2011:0622<\/td>\nRelated substances<\/td>\nspectrophotometer at 225\u00a0nm<\/td>\n<\/tr>\n
Megestrol acetate<\/td>\nPh. Eur. 01\/2014:1593<\/td>\nRelated substances<\/td>\nspectrophotometer at 245\u00a0nm<\/td>\n<\/tr>\n
Megestrol acetate<\/td>\nPh. Eur. 01\/2014:1593<\/td>\nAssay<\/td>\nspectrophotometer at 245\u00a0nm<\/td>\n<\/tr>\n
Megestrol acetate<\/td>\nPh. Eur. 01\/2014:1593<\/td>\nimpurity\u00a0J<\/td>\nspectrophotometer at 210 nm<\/td>\n<\/tr>\n
Meloxicam<\/td>\nPh. Eur. 07\/2015:2373<\/td>\nRelated substances<\/td>\nspectrophotometer at 260\u00a0nm and 350\u00a0nm<\/td>\n<\/tr>\n
Melphalan<\/td>\nPh. Eur. 07\/2012:1698<\/td>\nRelated substances<\/td>\nspectrophotometer at 260\u00a0nm<\/td>\n<\/tr>\n
Melphalan<\/td>\nPh. Eur. 07\/2012:1698<\/td>\nAssay<\/td>\nspectrophotometer at 260\u00a0nm<\/td>\n<\/tr>\n
Mesalazine<\/td>\nPh. Eur. 04\/2013:1699<\/td>\nImpurities\u00a0A and\u00a0C<\/td>\nspectrophotometer at 220\u00a0nm<\/td>\n<\/tr>\n
Mesalazine<\/td>\nPh. Eur. 04\/2013:1699<\/td>\nRelated substances<\/td>\nspectrophotometer at 240\u00a0nm<\/td>\n<\/tr>\n
Metformin hydrochloride<\/td>\nPh. Eur. 01\/2014:0931<\/td>\nImpurity\u00a0F<\/td>\nspectrophotometer at 380\u00a0nm<\/td>\n<\/tr>\n
Methionine<\/td>\nPh. Eur. 01\/2016:1027<\/td>\nRelated substances<\/td>\nspectrophotometer at 205\u00a0nm<\/td>\n<\/tr>\n
Methotrexate<\/td>\nPh. Eur. 01\/2015:0560<\/td>\nAssay<\/td>\nspectrophotometer at 280\u00a0nm<\/td>\n<\/tr>\n
Methotrexate<\/td>\nPh. Eur. 01\/2015:0560<\/td>\nRelated substances<\/td>\nspectrophotometer at 280\u00a0nm<\/td>\n<\/tr>\n
Methylaminolevulinate hydrochloride<\/td>\nPharmeuropa XXXX:3073<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 275 nm<\/td>\n<\/tr>\n
Methylergometrine maleate<\/td>\nPh. Eur. 07\/2009:1788<\/td>\nRelated substances<\/td>\nspectrophotometer at 310\u00a0nm<\/td>\n<\/tr>\n
Methylprednisolone<\/td>\nPh. Eur. 01\/2014:0561<\/td>\nAssay<\/td>\nspectrophotometer at 247\u00a0nm<\/td>\n<\/tr>\n
Methylprednisolone<\/td>\nPh. Eur. 01\/2014:0561<\/td>\nRelated substances<\/td>\nspectrophotometer at 247\u00a0nm<\/td>\n<\/tr>\n
Methylprednisolone<\/td>\nPharmeuropa XXXX:0561<\/td>\nAssay<\/td>\nspectrophotometer at 247\u00a0nm<\/td>\n<\/tr>\n
Methylprednisolone<\/td>\nPharmeuropa XXXX:0561<\/td>\nRelated substances<\/td>\nspectrophotometer at 247\u00a0nm<\/td>\n<\/tr>\n
Methylprednisolone acetate<\/td>\nPh. Eur. 01\/2016:0933<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Methyltestosterone<\/td>\nPh. Eur. 07\/2008:0410<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Methylthioninium chloride<\/td>\nPh. Eur. 01\/2016:1132<\/td>\nRelated substances<\/td>\nspectrophotometer at 246\u00a0nm<\/td>\n<\/tr>\n
Methylthioninium chloride<\/td>\nPh. Eur. 01\/2016:1132<\/td>\nAssay<\/td>\nspectrophotometer at 246\u00a0nm<\/td>\n<\/tr>\n
Metolazone<\/td>\nPh. Eur. 01\/2008:1757<\/td>\nRelated substances<\/td>\nspectrophotometer at 230\u00a0nm<\/td>\n<\/tr>\n
Metolazone<\/td>\nPh. Eur. 01\/2008:1757<\/td>\nAssay<\/td>\nspectrophotometer at 230\u00a0nm<\/td>\n<\/tr>\n
Metrifonate<\/td>\nPh. Eur. 01\/2008:1133<\/td>\nRelated substances<\/td>\nspectrophotometer at 210\u00a0nm<\/td>\n<\/tr>\n
Metronidazole benzoate<\/td>\nPh. Eur. 01\/2013:0934<\/td>\nRelated substances<\/td>\nspectrophotometer at 235\u00a0nm<\/td>\n<\/tr>\n
Mitomycin<\/td>\nPh. Eur. 01\/2008:1655<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Molgramostim concentrated solution<\/td>\nPh. Eur. 01\/2008:1641<\/td>\nPeptide mapping<\/td>\nspectrophotometer at 214\u00a0nm<\/td>\n<\/tr>\n
Molgramostim concentrated solution<\/td>\nPh. Eur. 01\/2008:1641<\/td>\nRelated proteins<\/td>\nspectrophotometer at 214\u00a0nm<\/td>\n<\/tr>\n
Molgramostim concentrated solution<\/td>\nPh. Eur. 01\/2008:1641<\/td>\nAssay<\/td>\nspectrophotometer at 214\u00a0nm<\/td>\n<\/tr>\n
Molsidomine<\/td>\nPh. Eur. 07\/2013:1701<\/td>\nRelated substances<\/td>\nspectrophotometer at 210\u00a0nm<\/td>\n<\/tr>\n
Montelukast sodium<\/td>\nPh. Eur. 01\/2012:2583<\/td>\nRelated substances<\/td>\nspectrophotometer at 238\u00a0nm<\/td>\n<\/tr>\n
Montelukast sodium<\/td>\nPh. Eur. 01\/2012:2583<\/td>\nAssay<\/td>\nspectrophotometer at 238\u00a0nm<\/td>\n<\/tr>\n
Montelukast sodium<\/td>\nPh. Eur. 01\/2012:2583<\/td>\nEnantiomeric purity<\/td>\nspectrophotometer at 280\u00a0nm<\/td>\n<\/tr>\n
Nabumetone<\/td>\nPh. Eur. 07\/2010:1350<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Nabumetone<\/td>\nPh. Eur. 07\/2010:1350<\/td>\nAssay<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Naloxone hydrochloride dihydrate<\/td>\nPh. Eur. 04\/2013:0729<\/td>\nImpurity\u00a0D<\/td>\nspectrophotometer at 210\u00a0nm<\/td>\n<\/tr>\n
Nandrolone decanoate<\/td>\nPh. Eur. 01\/2008:1992<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Narrow-leaved coneflower root<\/td>\nPharmeuropa XXXX:1821<\/td>\nAssay<\/td>\nspectrophotometer at 330 nm<\/td>\n<\/tr>\n
Nevirapine hemihydrate<\/td>\nPh. Eur. 01\/2013:2479<\/td>\nRelated substances<\/td>\nspectrophotometer at 282\u00a0nm<\/td>\n<\/tr>\n
Nevirapine hemihydrate<\/td>\nPh. Eur. 01\/2013:2479<\/td>\nAssay<\/td>\nspectrophotometer at 282\u00a0nm<\/td>\n<\/tr>\n
Nicotinamide<\/td>\nPh. Eur. 01\/2016:0047<\/td>\nRelated substances<\/td>\nspectrophotometer at 264\u00a0nm<\/td>\n<\/tr>\n
Nicotine<\/td>\nPh. Eur. 01\/2009:1452<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Nicotine ditartrate dihydrate<\/td>\nPh. Eur. 01\/2014:2599<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Nicotine resinate<\/td>\nPh. Eur. 01\/2015:1792<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Nicotine resinate<\/td>\nPh. Eur. 01\/2015:1792<\/td>\nAssay<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Nicotinic acid<\/td>\nPh. Eur. 01\/2011:0459<\/td>\nRelated substances<\/td>\nspectrophotometer at 250\u00a0nm<\/td>\n<\/tr>\n
Nifuroxazide<\/td>\nPh. Eur. 04\/2008:1999<\/td>\nRelated substances<\/td>\nspectrophotometer at 280\u00a0nm<\/td>\n<\/tr>\n
Nilutamide<\/td>\nPh. Eur. 07\/2008:2256<\/td>\nRelated substances<\/td>\nspectrophotometer at 230\u00a0nm<\/td>\n<\/tr>\n
Nitrazepam<\/td>\nPh. Eur. 04\/2010:0415<\/td>\nRelated substances<\/td>\nspectrophotometer at 270\u00a0nm<\/td>\n<\/tr>\n
Nizatidine<\/td>\nPh. Eur. 07\/2012:1453<\/td>\nAssay<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Nizatidine<\/td>\nPh. Eur. 07\/2012:1453<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm<\/td>\n<\/tr>\n
Norethisterone<\/td>\nPh. Eur. 01\/2008:0234<\/td>\nRelated substances<\/td>\nvariable wavelength spectrophotometer capable of operating at 254\u00a0nm and at 210\u00a0nm<\/td>\n<\/tr>\n
Norethisterone acetate<\/td>\nPh. Eur. 04\/2013:0850<\/td>\nRelated substances<\/td>\nspectrophotometer at 254\u00a0nm and, for impurities B and C, at 210\u00a0nm<\/td>\n<\/tr>\n
Norfloxacin<\/td>\nPh. Eur. 04\/2011:1248<\/td>\nRelated substances<\/td>\nspectrophotometer at 265\u00a0nm<\/td>\n<\/tr>\n
Norfloxacin<\/td>\nPharmeuropa XXXX:1248<\/td>\nRelated substances<\/td>\nspectrophotometer at 265 nm<\/td>\n<\/tr>\n
Nystatin<\/td>\nPh. Eur. 01\/2008:0517<\/td>\nComposition<\/td>\nspectrophotometer at 305\u00a0nm<\/td>\n<\/tr>\n
Olmesartan medoxomil<\/td>\nPh. Eur. 04\/2012:2600<\/td>\nRelated substances<\/td>\nspectrophotometer at 250\u00a0nm<\/td>\n<\/tr>\n
Oxazepam<\/td>\nPh. Eur. 01\/2008:0778<\/td>\nRelated substances<\/td>\nspectrophotometer at 235\u00a0nm<\/td>\n<\/tr>\n
Oxymetazoline hydrochloride<\/td>\nPh. Eur. 01\/2013:0943<\/td>\nRelated substances<\/td>\nspectrophotometer at 220\u00a0nm<\/td>\n<\/tr>\n
Oxytocin<\/td>\nPh. Eur. 01\/2008:0780<\/td>\nRelated substances<\/td>\nspectrophotometer at 220\u00a0nm<\/td>\n<\/tr>\n
Oxytocin<\/td>\nPh. Eur. 01\/2008:0780<\/td>\nAssay<\/td>\nspectrophotometer at 220\u00a0nm<\/td>\n<\/tr>\n
Oxytocin concentrated solution<\/td>\nPh. Eur. 01\/2008:0779<\/td>\nRelated substances<\/td>\nspectrophotometer at 220\u00a0nm<\/td>\n<\/tr>\n
Oxytocin concentrated solution<\/td>\nPh. Eur. 01\/2008:0779<\/td>\nAssay<\/td>\nspectrophotometer at 220\u00a0nm<\/td>\n<\/tr>\n
Paclitaxel<\/td>\nPh. Eur. 01\/2009:1794<\/td>\nRelated substances A<\/td>\nspectrophotometer at 227\u00a0nm<\/td>\n<\/tr>\n
Paclitaxel<\/td>\nPh. Eur. 01\/2009:1794<\/td>\nAssay B<\/td>\nspectrophotometer at 227\u00a0nm<\/td>\n<\/tr>\n
Paclitaxel<\/td>\nPh. Eur. 01\/2009:1794<\/td>\nRelated substances B<\/td>\nspectrophotometer at 227\u00a0nm<\/td>\n<\/tr>\n
Paclitaxel<\/td>\nPh. Eur. 01\/2009:1794<\/td>\nAssay A<\/td>\nspectrophotometer at 227\u00a0nm<\/td>\n<\/tr>\n
Pale coneflower root<\/td>\nPharmeuropa XXXX:1822<\/td>\nAssay<\/td>\nspectrophotometer at 330 nm<\/td>\n<\/tr>\n
Pantoprazole sodium sesquihydrate<\/td>\nPh. Eur. 04\/2008:2296<\/td>\nRelated substances<\/td>\nspectrophotometer at 290\u00a0nm and, for impurity\u00a0C, at 305\u00a0nm<\/td>\n<\/tr>\n
Papaverine hydrochloride<\/td>\nPh. Eur. 01\/2008:0102<\/td>\nRelated substances<\/td>\nspectrophotometer at 238\u00a0nm<\/td>\n<\/tr>\n
Paracetamol<\/td>\nPharmeuropa XXXX:0049<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 254 nm<\/td>\n<\/tr>\n
Paroxetine hydrochloride<\/td>\nPharmeuropa XXXX:2283<\/td>\nRelated compounds<\/td>\nspectrophotometer at 295\u00a0nm<\/td>\n<\/tr>\n
Paroxetine hydrochloride hemihydrate<\/td>\nPharmeuropa XXXX:2018<\/td>\nRelated compounds<\/td>\nspectrophotometer at 295 nm<\/td>\n<\/tr>\n
Paroxetine hydrochloride hemihydrate<\/td>\nPh. Eur. 01\/2008:2018<\/td>\nRelated substances<\/td>\nspectrophotometer at 295\u00a0nm<\/td>\n<\/tr>\n
Paroxetine hydrochloride, anhydrous<\/td>\nPh. Eur. 01\/2008:2283<\/td>\nRelated substances<\/td>\nspectrophotometer at 295\u00a0nm<\/td>\n<\/tr>\n
Paroxetine hydrochloride, anhydrous<\/td>\nPh. Eur. 01\/2008:2283<\/td>\nImpurities H and I<\/td>\nspectrophotometer at 263\u00a0nm<\/td>\n<\/tr>\n
Pemetrexed disodium heptahydrate<\/td>\nPh. Eur. 04\/2013:2637<\/td>\nRelated substances<\/td>\nspectrophotometer at 250\u00a0nm<\/td>\n<\/tr>\n
Pentoxifylline<\/td>\nPh. Eur. 01\/2008:0851<\/td>\nRelated substances<\/td>\nspectrophotometer at 272\u00a0nm<\/td>\n<\/tr>\n
Perindopril tert-butylamine<\/td>\nPh. Eur. 01\/2008:2019<\/td>\nRelated substances<\/td>\nspectrophotometer at 215\u00a0nm<\/td>\n<\/tr>\n
PSMA-1007 (18F) injection<\/td>\nPharmeuropa XXXX:3116<\/td>\nPSMA-1007 and related substances<\/td>\nspectrophotometer at 255\u00a0nm<\/td>\n<\/tr>\n
Purple coneflower herb<\/td>\nPharmeuropa XXXX:1823<\/td>\nAssay<\/td>\nspectrophotometer at 330 nm<\/td>\n<\/tr>\n
Purple coneflower root<\/td>\nPharmeuropa XXXX:1824<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 330 nm<\/td>\n<\/tr>\n
Rabeprazole sodium<\/td>\nPharmeuropa XXXX:2868<\/td>\nRelated substances<\/td>\nspectrophotometer at 280\u00a0nm<\/td>\n<\/tr>\n
Rabeprazole sodium<\/td>\nPharmeuropa XXXX:2868<\/td>\nAssay<\/td>\nspectrophotometer at 280\u00a0nm<\/td>\n<\/tr>\n
Raltegravir tablets<\/td>\nPharmeuropa XXXX:2938<\/td>\nRelated substances<\/td>\nspectrophotometer at 220\u00a0nm<\/td>\n<\/tr>\n
Raltegravir tablets<\/td>\nPharmeuropa XXXX:2938<\/td>\nAssay<\/td>\nspectrophotometer at 220\u00a0nm<\/td>\n<\/tr>\n
Regorafenib tablets<\/td>\nPharmeuropa XXXX:3023<\/td>\nRelated substances<\/td>\nspectrophotometer at 260\u00a0nm<\/td>\n<\/tr>\n
Regorafenib tablets<\/td>\nPharmeuropa XXXX:3023<\/td>\nImpurity A<\/td>\nspectrophotometer at 228\u00a0nm<\/td>\n<\/tr>\n
Regorafenib tablets<\/td>\nPharmeuropa XXXX:3023<\/td>\nAssay<\/td>\nspectrophotometer at 260\u00a0nm<\/td>\n<\/tr>\n
Riociguat<\/td>\nPharmeuropa XXXX:3078<\/td>\nRelated substances<\/td>\nspectrophotometer at 210\u00a0nm<\/td>\n<\/tr>\n
Riociguat<\/td>\nPharmeuropa XXXX:3078<\/td>\nAssay<\/td>\nspectrophotometer at 210\u00a0nm<\/td>\n<\/tr>\n
Rivaroxaban tablets<\/td>\nPharmeuropa XXXX:3021<\/td>\nRelated substances<\/td>\nspectrophotometer at 250 nm<\/td>\n<\/tr>\n
Rivaroxaban tablets<\/td>\nPharmeuropa XXXX:3021<\/td>\nAssay<\/td>\nspectrophotometer at 250 nm<\/td>\n<\/tr>\n
Sanguinaria for homoeopathic preparations<\/td>\nPharmeuropa XXXX:2687<\/td>\nAssay<\/td>\nspectrophotometer at 275\u00a0nm<\/td>\n<\/tr>\n
Sodium aminosalicylate dihydrate<\/td>\nPharmeuropa XXXX:1993<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 220 nm<\/td>\n<\/tr>\n
Sorafenib tablets<\/td>\nPharmeuropa XXXX:3022<\/td>\nRelated substances<\/td>\nspectrophotometer at 235\u00a0nm<\/td>\n<\/tr>\n
Sorafenib tablets<\/td>\nPharmeuropa XXXX:3022<\/td>\nAssay<\/td>\nspectrophotometer at 235\u00a0nm<\/td>\n<\/tr>\n
Sorafenib tosilate<\/td>\nPharmeuropa XXXX:2931<\/td>\nRelated substances<\/td>\nspectrophotometer at 235\u00a0nm<\/td>\n<\/tr>\n
Sorafenib tosilate<\/td>\nPharmeuropa XXXX:2931<\/td>\nAssay<\/td>\nspectrophotometer at 235\u00a0nm<\/td>\n<\/tr>\n
Teriflunomide<\/td>\nPharmeuropa XXXX:3036<\/td>\nAssay<\/td>\nspectrophotometer at 249 nm<\/td>\n<\/tr>\n
Teriflunomide<\/td>\nPharmeuropa XXXX:3036<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 249 nm<\/td>\n<\/tr>\n
Ticagrelor<\/td>\nPharmeuropa XXXX:3087<\/td>\nAssay<\/td>\nspectrophotometer at 242\u00a0nm<\/td>\n<\/tr>\n
Ticagrelor<\/td>\nPharmeuropa XXXX:3087<\/td>\nImpurity E<\/td>\nspectrophotometer at 222\u00a0nm<\/td>\n<\/tr>\n
Ticagrelor<\/td>\nPharmeuropa XXXX:3087<\/td>\nRelated substances<\/td>\nspectrophotometer at 242\u00a0nm<\/td>\n<\/tr>\n
Ticagrelor tablets<\/td>\nPharmeuropa XXXX:3097<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 242\u00a0nm<\/td>\n<\/tr>\n
Tigecycline<\/td>\nPharmeuropa XXXX:2825<\/td>\nRelated substances<\/td>\nspectrophotometer at 248 nm<\/td>\n<\/tr>\n
Valganciclovir hydrochloride<\/td>\nPharmeuropa XXXX:2930<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 254 nm<\/td>\n<\/tr>\n
Valganciclovir hydrochloride<\/td>\nPharmeuropa XXXX:2930<\/td>\nAssay<\/td>\nspectrophotometer at 254 nm<\/td>\n<\/tr>\n
Xylazine hydrochloride for veterinary use<\/td>\nPharmeuropa XXXX:1481<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 230 nm<\/td>\n<\/tr>\n
Zidovudine<\/td>\nPharmeuropa XXXX:1059<\/td>\nRelated Compounds<\/td>\nspectrophotometer at 265 nm<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Applikation DK29 Applikation DK02 Applikation DJ16 Applikation LC001833 Applikation LC001789 \u00a0Applikation LC000831 \u00a0 Applikation LC00826 Applikation LC000857 Applikation LC001776 Applikation LC002342 – UV 243 nm Applikation LC002342 – UV 274 nm Gradientenmethoden aus European Pharmacopoeia (Ph. Eur.) \/ Pharmeuropa Monographien bei denen die Ghost-Guard-LC eingesetzt werden kann Substance Monograph Test Detection Aciclovir Pharmeuropa XXXX:0968 Related […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"class_list":["post-6","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/analyte.de\/index.php?rest_route=\/wp\/v2\/pages\/6","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyte.de\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/analyte.de\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/analyte.de\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyte.de\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6"}],"version-history":[{"count":57,"href":"https:\/\/analyte.de\/index.php?rest_route=\/wp\/v2\/pages\/6\/revisions"}],"predecessor-version":[{"id":732,"href":"https:\/\/analyte.de\/index.php?rest_route=\/wp\/v2\/pages\/6\/revisions\/732"}],"wp:attachment":[{"href":"https:\/\/analyte.de\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}